Estimated reading time: 6 minutes
Key Takeaways
- *Nvidia’s 20 % share-price decline in early 2025 has created a potential buying window for long-term investors*
- Demand for AI infrastructure remains **robust**, even as export rules cloud near-term revenue
- UBS strategists call the sell-off “excessive” and reiterate an outperform rating
- Partial easing of US chip restrictions and hefty capex plans from hyperscalers may underpin a rebound
- Investors must still weigh *geopolitics, tariffs and sector volatility* before adding exposure
Table of Contents
Current Performance of Nvidia Stock
Nvidia (NVDA) began 2025 near its January peak of $149.43, plummeted below $100 in April and then roared back to roughly $173 by July. The see-saw journey has pushed market capitalisation above the $4 trillion mark, highlighting the *tug-of-war between regulatory fears and AI optimism*.
According to Reuters data, option-implied volatility hovers near multi-year highs, reinforcing the notion that chip stocks remain the market’s high-beta play.
Reasons Behind the Pull-Back
AI hardware demand is booming, yet export curbs have barred Nvidia’s most advanced GPUs from key Chinese hyperscalers, resulting in a $5.5 billion inventory write-down on H20 chips.
- US–China tariff tit-for-tat now stands at 145 % and 125 %, respectively, compressing gross margins
- Higher real yields have trimmed growth-stock multiples across the tech complex
- Competition from new AMD MI-series accelerators and custom silicon by cloud giants intensifies the pricing debate
“The market is discounting a worst-case scenario that looks increasingly unlikely given the pace of AI adoption,” remarks Dan Ives of Wedbush in a recent CNBC interview.
UBS View on the Opportunity
UBS analysts argue the **20 % slump** represents an *overreaction* to transitory policy noise. Their base-case target of $214 implies ~24 % upside from current levels, while a bull-case scenario stretches to $278 on the assumption of looser export caps.
The Swiss bank highlights Nvidia’s unmatched software stack—including CUDA, cuDNN and TensorRT—as a fundamental moat that rivals cannot easily replicate.
Growth Prospects & Recovery Potential
Fourth-quarter 2025 revenue hit $39.3 billion, up 12 % quarter-on-quarter and 78 % year-on-year, while full-year top line surged 114 % to $130.5 billion. These numbers, confirmed in Nvidia’s latest 10-K filing, indicate that AI-driven demand is handily outstripping regulatory drag.
Looking ahead, generative-AI workloads spanning healthcare, gaming and enterprise productivity form a long runway for GPU shipments. Should Washington further relax chip-export licensing and macro-data continue to stabilise, historical drawdowns suggest a *swift relief rally is plausible*.
Key Considerations for Investors
- Geopolitics: export controls, tariffs and potential sanctions can re-price the stock overnight
- Valuation: at ~31× forward EPS, Nvidia trades at the upper end of its historical range
- Competition: custom AI chips from Google TPU and Amazon’s Trainium lines could erode market share over time
- Volatility: implied one-year move remains above 55 %, demanding disciplined position sizing
FAQs
Is Nvidia still a growth stock after the 2025 slump?
Yes. Revenue growth north of 100 % year-on-year and expanding AI-chip demand confirm its growth profile, though investors must stomach higher volatility.
What could trigger a sustained rebound?
Key catalysts include any relaxation of US export rules, fresh cloud-provider capex announcements and softer inflation data that revives risk appetite.
How important is China to Nvidia’s long-term story?
Historically China contributed 20–25 % of data-center revenue. While the market is currently restricted, eventual policy thaw could restore this growth vector.
Does rising competition diminish Nvidia’s moat?
Rivals are closing the hardware gap, but Nvidia’s end-to-end platform—hardware, software and developer ecosystem—remains a formidable barrier.
Should investors wait for clearer regulation before buying?
Risk-averse investors might, but history shows that *buying during regulatory overhangs* has often yielded outsized returns once uncertainty fades.
